跳至主要内容
临床试验/NCT04180462
NCT04180462已完成不适用

Randomized Controlled Trial to Evaluate an Implementation Strategy to Increase Optimal Use of HPV Vaccine in Primary Care

Washington University School of Medicine2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2020年1月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Initiation of the HPV Vaccine 2-dose Series.

研究概览

简要总结

Washington University will evaluate the effectiveness of a multi-component implementation strategy to increase use of HPV vaccine in primary care practices.

详细描述

The investigators at Washington University will complete a cluster-randomized trial to evaluate the effectiveness of a multi-component implementation strategy (the intervention) to increase use of the HPV vaccine according to CDC guidelines. The unit of randomization is a community-based, primary care pediatric practice. Twenty practices will be randomized into two groups, the intervention group (n=10) or a wait-list control group (n=10). The intervention will be implemented over 2-years and includes: 1) an educational video for providers; 2) audit and feedback of vaccine coverage; 3) a communication strategy; and 4) practice facilitation.

The primary outcome of HPV vaccination by age 13 will be assessed at 24 months, and at 36 months to assess if change is sustained.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Initiation of the HPV Vaccine 2-dose Series.

时间窗: 24 months

The proportion of eligible preteens who initiate the HPV vaccine before their 13th birthday, at 24 months, post randomization

Completion of the HPV Vaccine 2-dose Series.

时间窗: 24 months

The proportion of eligible preteens who complete the HPV vaccine before their 13th birthday, at 24 months, post randomization.

次要结局

  • Sustainability of the Intervention Benefit for Initiation of the HPV Vaccine.(36 months)
  • Sustainability of the Intervention Benefit for Completion of the HPV Vaccine.(36 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Increasing Optimal Use of HPV Vaccination in Primary... | 临床试验